Unsurprisingly, mortality was higher with concurrent COVID-19.
There is interest in how COVID-19 is affecting the care of patients with cardiovascular disease. In the current retrospective study, researchers used a national database of administrative claims to examine associations between COVID-19 infection and treatment and outcomes of patients hospitalized with ST-segment elevation myocardial infarction (STEMI).
Among 76,434 patients with an out-of-hospital STEMI, investigators matched a group of 551 patients with COVID-19 and 2755 without COVID-19. Among 4015 patients with an in-hospital STEMI, they matched 252 with COVID-19 and 756 without COVID-19. For the out-of-hospital group, the likelihood of undergoing percutaneous coronary intervention was not significantly different by COVID-19 status, but f…
Reviewing Author
DisclosuresConsultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime
EquityHugo Health; Refactor Health; Element Science
Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association
DisclosuresConsultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime
EquityHugo Health; Refactor Health; Element Science
Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association